You may have heard of the Chinese business concept of guanxi, but do you really understand it? The term, loosely defined as "relationship," can be maligned in the West, but there's more to it than cronyism.
The Food and Drug Law Institute held its first conference in China June 13-14 in Beijing to try to tackle some of the persisting challenges of doing business in China. They gathered top-notch speakers from FDA, China's SFDA, and some of the leading regulatory and legal experts from companies operating in China (not to mention our own PharmAsia News – see our coverage here and here; or register for a free trial here).
To read the rest of the post and hear our exclusive podcast from the Food and Drug Law Institute's guest panel click here
To read the rest of the post and hear our exclusive podcast from the Food and Drug Law Institute's guest panel click here
Comments